Back to top
more

CymaBay Therapeutics Inc. (CBAY)

(Delayed Data from NSDQ)

$13.12 USD

13.12
454,386

+0.67 (5.38%)

Updated May 3, 2019 04:00 PM ET

After-Market: $13.12 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks News

Zacks.com featured highlights: Apollo Investment, Ballard Power Systems, Cymabay Therapeutics, Fate Therpautics and Oclaro

Zacks.com featured highlights: Apollo Investment, Ballard Power Systems, Cymabay Therapeutics, Fate Therpautics and Oclaro

    Kevin Matras headshot

    Explosive Stocks Under $10

    Kevin Matras looks for stocks under $10 with explosive potential. Highlighted stocks include AINV, BLDP, CBAY, FATE and OCLR.

      Progenics Pharmaceuticals (PGNX) in Focus: Stock Gains 8.3%

      Progenics Pharmaceuticals (PGNX) saw its shares rise above 8% in the last trading session.

        The Zacks Analyst Blog Highlights: Cymabay Therapeutics, Attunity, Lumentum Holdings, Datawatch and Arconic

        The Zacks Analyst Blog Highlights: Cymabay Therapeutics, Attunity, Lumentum Holdings, Datawatch and Arconic

          Swarup Gupta headshot

          5 Top Performers of Trump's First 30 Days in Office

          Trump indicated these gains were largely attributable to the positive sentiment generated by his victory.

            Tirthankar Chakraborty headshot

            New Strong Buy Stocks for February 21st

            Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday

              Can The Uptrend Continue for Cymabay Therapeutics (CBAY)?

              Investors certainly have to be happy with Cymabay Therapeutics, Inc. (CBAY) and its short term performance

                Cerner's EHR Platform to Enhance Health Care at San Juan NGO

                Cerner Corporation (CERN) announced that it recently entered into an agreement to provide San Juan Regional Medical Center with a new electronic health record platform.

                  Swarup Gupta headshot

                  5 Breakout Stocks for Superior Returns

                  If properly implemented, such a strategy could deliver impressive returns.

                    Cymabay Therapeutics (CBAY) Rises: Stock Moves 9.2% Higher

                    Cymabay Therapeutics, Inc. (CBAY) shares rose over 9% in the last trading session.